Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangfuxin Solution for prevention and treatment of chemoradiotherapy-induced oral mucositis in nasopharyngeal carcinoma
ChiCTR-IPR-15006687Phase 4Completed
- Sponsor
- Sichuan Cancer Hospital
- Start
- Jul 2012
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kangfuxin in stomatitis and gastrointestinal mucositis (2 arms), sponsored by Sichuan Cancer Hospital. Primary endpoint: oral mucositis. Started Jul 2012; status: completed.
02
Drugs
kangfuxin
03
Conditions
stomatitisgastrointestinal mucositis
Beyond the preview
Go deeper on ChiCTR-IPR-15006687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006687.